(Q57216466)

1

0 references

Mitchell S Cairo

2

0 references

Prakash Satwani

3

0 references

David L Zwick

4

0 references

Mark A Lones

5

0 references

Richard Sposto

6

0 references

Minnie Abromovitch

7

0 references

Sheryl Tripp

8

0 references

Anne L Angiolillo

9

0 references

Elizabeth Roman

10

0 references

Virginia Davenport

11

0 references

Sherrie L Perkins

British Journal of Haematology

12

0 references

language of work or name

English

0 references

publication date

August 2007

0 references

published in

0 references

volume

138

0 references

issue

4

0 references

page(s)

506-12

0 references

cites work

Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Invariant chain structure and MHC class II function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

The CD52 antigen and development of the CAMPATH antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Non-Hodgkin's lymphoma in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X

Primary structure of CD52.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06689.X